Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC)

Burn, J Alonso, A Bertario, L Bishop, T Bisgaard, ML Cummings, J Davidson, R Delhanty, J Demant, P Dunlop, M Eccles, D Ellis, A Evans, G Fidalgo, P Fodde, R Haites, N Hodgson, S Hultcrantz, R Huson, S Jarvinen, H Kartheuser, A Kleibeuker, J Lenaerts, C Lucasson, A Lunt, P McDermot, K McKay, J McKeown, C Maher, E Mathers, J Mecklin, JP Moslein, G Murday, V Nagengast, F Northover, JMA Obrador, A Parks, TG Paraskeva, C Phillips, R San Roman, C Ruscheoff, J Sampson, J Shepherd, N Tempesta, A Trembath, R Turnpenny, P Vasen, HFA

J. Burn et al., Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC), BIOM HLTH R, 24, 1998, pp. 17-23

Current Book Contents

CANCER RESEARCH SUPPORTED UNDER BIOMED I → ACNP

09296743

24

1998

17 - 23

ISI

0929-6743(1998)24:<17:CAPPCA>2.0.ZU;2-Z